FGFR4 and breast neoplasm: The corollary of the tumor-suppressive effects of the FGFR4 deficiency in the breast is that chronic activity of hepatic FGFR4 and its systemic endocrine effects may contribute to promotion of breast tumors via the inverse of the changes in systemic adipokines and factors and local metabolic reprogramming we reported here.